lysergic acid diethylamide has been researched along with Agoraphobia in 2 studies
Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.
Agoraphobia: Obsessive, persistent, intense fear of open places.
Excerpt | Relevance | Reference |
---|---|---|
"Patients ultimately presented for treatment of agoraphobia." | 1.27 | Depersonalization and agoraphobia associated with marijuana use. ( Moran, C, 1986) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Norman, TR | 1 |
Judd, FK | 1 |
Staikos, V | 1 |
Burrows, GD | 1 |
McIntyre, IM | 1 |
Moran, C | 1 |
2 other studies available for lysergic acid diethylamide and Agoraphobia
Article | Year |
---|---|
High-affinity platelet [3H]LSD binding is decreased in panic disorder.
Topics: Adult; Agoraphobia; Blood Platelets; Fear; Female; Humans; Lysergic Acid Diethylamide; Male; Middle | 1990 |
Depersonalization and agoraphobia associated with marijuana use.
Topics: Adult; Agoraphobia; Behavior Therapy; Cannabis; Depersonalization; Female; Humans; Lysergic Acid Die | 1986 |